Elahere
Elahere Fully Approved for Certain Ovarian, Fallopian Tube or Primary Peritoneal Cancer
The FDA approved Elahere for adult patients with FRalpha-positive, platinum-resistant epithelial ovarian, fallopian ...
MARCH 25, 2024
FDA Approves Elahere to Treat Platinum-Resistant Ovarian Cancer
Mirvetuximab soravtansine-gynx was approved to treat adults with folate receptor alpha-positive, platinum-resistant ...
NOVEMBER 21, 2022
Load more